These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 17217330)

  • 1. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy.
    Boucher RC
    Annu Rev Med; 2007; 58():157-70. PubMed ID: 17217330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for airway surface dehydration as the initiating event in CF airway disease.
    Boucher RC
    J Intern Med; 2007 Jan; 261(1):5-16. PubMed ID: 17222164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis: a disease of vulnerability to airway surface dehydration.
    Boucher RC
    Trends Mol Med; 2007 Jun; 13(6):231-40. PubMed ID: 17524805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
    Tarran R; Donaldson S; Boucher RC
    Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress.
    Tarran R; Button B; Boucher RC
    Annu Rev Physiol; 2006; 68():543-61. PubMed ID: 16460283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of cyclic and constant stress on ATP release and mucociliary transport by human airway epithelia.
    Button B; Picher M; Boucher RC
    J Physiol; 2007 Apr; 580(Pt. 2):577-92. PubMed ID: 17317749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways.
    Garland AL; Walton WG; Coakley RD; Tan CD; Gilmore RC; Hobbs CA; Tripathy A; Clunes LA; Bencharit S; Stutts MJ; Betts L; Redinbo MR; Tarran R
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):15973-8. PubMed ID: 24043776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathology of Airway Surface Liquid Dehydration Disease.
    Lewis BW; Patial S; Saini Y
    J Immunol Res; 2019; 2019():2180409. PubMed ID: 31396541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical model reveals role of nucleotide signaling in airway surface liquid homeostasis and its dysregulation in cystic fibrosis.
    Sandefur CI; Boucher RC; Elston TC
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7272-E7281. PubMed ID: 28808008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?
    Tiddens HA; Donaldson SH; Rosenfeld M; Paré PD
    Pediatr Pulmonol; 2010 Feb; 45(2):107-17. PubMed ID: 20082341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.
    Haq IJ; Gray MA; Garnett JP; Ward C; Brodlie M
    Thorax; 2016 Mar; 71(3):284-7. PubMed ID: 26719229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early cystic fibrosis lung disease: Role of airway surface dehydration and lessons from preventive rehydration therapies in mice.
    Mall MA; Graeber SY; Stahl M; Zhou-Suckow Z
    Int J Biochem Cell Biol; 2014 Jul; 52():174-9. PubMed ID: 24561284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Protease-Epithelial Sodium Channel Signaling Improves Mucociliary Function in Cystic Fibrosis Airways.
    Reihill JA; Walker B; Hamilton RA; Ferguson TE; Elborn JS; Stutts MJ; Harvey BJ; Saint-Criq V; Hendrick SM; Martin SL
    Am J Respir Crit Care Med; 2016 Sep; 194(6):701-10. PubMed ID: 27014936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology.
    Clunes MT; Boucher RC
    Methods Mol Biol; 2011; 742():3-14. PubMed ID: 21547723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease.
    Matsui H; Grubb BR; Tarran R; Randell SH; Gatzy JT; Davis CW; Boucher RC
    Cell; 1998 Dec; 95(7):1005-15. PubMed ID: 9875854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucociliary clearance as an outcome measure for cystic fibrosis clinical research.
    Donaldson SH; Corcoran TE; Laube BL; Bennett WD
    Proc Am Thorac Soc; 2007 Aug; 4(4):399-405. PubMed ID: 17652507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epithelium as a target for therapy in cystic fibrosis.
    Thelin WR; Boucher RC
    Curr Opin Pharmacol; 2007 Jun; 7(3):290-5. PubMed ID: 17475561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled hypertonic saline as a therapy for cystic fibrosis.
    Elkins MR; Bye PT
    Curr Opin Pulm Med; 2006 Nov; 12(6):445-52. PubMed ID: 17053496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.